ACT001(DMAMCL)
ACT001(DMAMCL, dimethylaminomicheliolide) is a PAI-1 inhibitor and exerts antitumor effects on neuroblastoma (NB) both in vitro and in vivo. It also exerts synergistic effects in combination with cisplatin through the inhibition of the PAI-1/PI3K/AKT pathway.
| Trivial name | DMAMCL, dimethylaminomicheliolide |
| Catalog Number | E1603 |
| Molecular Formula | C17H27NO3 |
| CAS# | 1403357-81-2 |
| Size | 5mg |
| Supplier Page | http://www.selleckchem.com/products/act001-dmamcl.html |
| Additional Information | https://file.selleck.cn/downloads/struct/e1603-ACT001-DMAMCL-chemical-structure.png |